Sarah A Dunlop Selected Research

zinc thionein

5/2012

Burn injury has a systemic effect on reinnervation of skin and restoration of nociceptive function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sarah A Dunlop Research Topics

Disease

10	Spinal Cord Injuries (Spinal Cord Injury) 07/2022 - 03/2013
4	Optic Nerve Injuries 07/2018 - 05/2007
4	Wounds and Injuries (Trauma) 01/2014 - 09/2008
2	Urinary Tract Infections (Urinary Tract Infection) 07/2022 - 01/2020
2	Quadriplegia (Spastic Quadriplegia) 10/2017 - 04/2016
2	Facial Nerve Injuries 03/2016 - 01/2009
2	Burns 05/2012 - 09/2008
2	Brain Injuries (Brain Injury) 05/2008 - 05/2007
1	Major Depressive Disorder (Major Depressive Disorders) 01/2022
1	Inflammation (Inflammations) 01/2020
1	Breast Neoplasms (Breast Cancer) 10/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Gliosis 03/2016
1	Spinal Injuries (Spinal Injury) 01/2016
1	Osteoporosis 01/2015
1	Retinal Degeneration 01/2014
1	Nervous System Diseases (Neurological Disorders) 03/2013
1	Body Weight (Weight, Body) 03/2013
1	Birth Weight (Birth Weights) 01/2012
1	Glaucoma 03/2010
1	Hypertrophy 02/2010
1	Necrosis 11/2009
1	Retinal Neovascularization 10/2006
1	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2006
1	Ganglion Cysts (Ganglion) 05/2002
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2002

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2008
2	Biomarkers (Surrogate Marker)IBA 07/2018 - 01/2015
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 03/2016 - 01/2009
2	lomerizineIBA 03/2010 - 11/2009
1	ChondroitinIBA 07/2022
1	Hyaluronic Acid (Hyaluronan)IBA 07/2022
1	Pharmaceutical PreparationsIBA 10/2019
1	hydroxyethyl methacrylate (HEMA)IBA 10/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2019
1	LipopolysaccharidesIBA 01/2019
1	SynucleinsIBA 01/2019
1	alpha-SynucleinIBA 01/2019
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2018
1	8-hydroxyguanosineIBA 01/2014
1	salicylhydroxamic acid (SHAM)IBA 03/2013
1	Cholinergic Agents (Cholinergics)IBA 03/2013
1	zinc thioneinIBA 05/2012
1	Naltrexone (ReVia)FDA LinkGeneric 01/2012
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 03/2010
1	Myelin Basic ProteinIBA 02/2010
1	Caspase 3 (Caspase-3)IBA 11/2009
1	Cysteine (L-Cysteine)FDA Link 09/2008
1	MetallothioneinIBA 09/2008
1	CytokinesIBA 05/2007
1	Erythropoietin FDA Link 05/2007
1	Hormones (Hormone)IBA 05/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2006
1	Retinaldehyde (Retinal)IBA 10/2006
1	Rhodopsin (Visual Purple)IBA 10/2006
1	cresyl violetIBA 05/2002
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2002

Therapy/Procedure

8	Therapeutics 06/2018 - 05/2012
1	Transcranial Magnetic Stimulation 01/2022
1	Length of Stay 01/2020
1	Secondary Prevention 11/2016
1	Decompression 01/2016
1	Lasers (Laser) 01/2014
1	Axotomy 05/2007